Literature DB >> 16610571

Metastatic malignant melanoma of the gastrointestinal tract.

Kelly V Liang1, Schuyler O Sanderson, Grzegorz S Nowakowski, Amindra S Arora.   

Abstract

Malignant melanoma is one of the most common malignancies to metastasize to the gastrointestinal (GI) tract. Metastases to the GI tract can present at the time of primary diagnosis or decades later as the first sign of recurrence. Symptoms may include abdominal pain, dysphagia, small bowel obstruction, hematemesis, and melena. We report 2 cases of malignant melanoma metastatic to the GI tract, followed by a review of the literature. The first case is a 72-year-old man who underwent resection of superficial spreading melanoma on his back 13 years previously who presented with dysphagia. A biopsy specimen of a mucosal fold in a gastric fundus noted during endoscopy was taken and revealed metastatic malignant melanoma, which was resected 1 month later. Three weeks later, the patient was found to have an ulcerated jejunal metastatic melanoma mass, which was also resected. The second case is a 63-year-old man with an ocular melanoma involving the chorold of the left eye that had been diagnosed 4 years previously, which had been excised several times, who presented with anorexia, dizziness, and fatigue. He was found to have cerebellar and stomach metastases. He underwent adjuvant radiation therapy, chemotherapy, and surgical resection of the gastric melanoma metastasis. In patients with a history of melanoma, a high index of suspicion for metastasis must be maintained if they present with seemingly unrelated symptoms. Diagnosis requires careful inspection of the mucosa for metastatic lesions and biopsy with special immunohistochemical stains. Management may include surgical resection, chemotherapy, immunotherapy, observation, or enrollment in clinical trials. Prognosis is poor, with a median survival of 4 to 6 months.

Entities:  

Mesh:

Year:  2006        PMID: 16610571     DOI: 10.4065/81.4.511

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  46 in total

1.  Diffuse gastroduodenal metastasis from cutaneous malignant melanoma presenting as amelanotic "volcano-like" ulcers.

Authors:  Hamid Shaaban; Yashpal Modi; Tejas Modi; Gunwant Guron
Journal:  J Gastrointest Cancer       Date:  2014-03

2.  Gastric malignant melanoma.

Authors:  Goundappa Loganathan; Pradyumn Singh
Journal:  Indian J Gastroenterol       Date:  2014-03

3.  Anti-cancer effects of enteric-coated polymers containing mistletoe lectin in murine melanoma cells in vitro and in vivo.

Authors:  Seung-Yeon Han; Chang-Eui Hong; Hwan-Gyu Kim; Su-Yun Lyu
Journal:  Mol Cell Biochem       Date:  2015-07-09       Impact factor: 3.396

Review 4.  Small bowel wall thickening: MDCT evaluation in the emergency room.

Authors:  Seray Akcalar; Baris Turkbey; Musturay Karcaaltincaba; Erhan Akpinar; Okan Akhan
Journal:  Emerg Radiol       Date:  2011-06-17

5.  A patient with metastatic melanoma presenting with gastrointestinal perforation after dacarbazine infusion: a case report.

Authors:  Sjoukje F Oosting; Frans Tm Peters; Geke Ap Hospers; Nanno H Mulder
Journal:  J Med Case Rep       Date:  2010-01-15

Review 6.  Review.

Authors:  Leonard B Weinstock; Rajesh S Shah
Journal:  Gastroenterol Hepatol (N Y)       Date:  2006-11

7.  Primary gastric malignant melanoma mimicking adenocarcinoma.

Authors:  Jun-Min Cho; Chang Min Lee; You-Jin Jang; Sung-Soo Park; Seong-Heum Park; Seung-Joo Kim; Young-Jae Mok; Chong-Suk Kim; Ju-Han Lee; Jong-Han Kim
Journal:  J Gastric Cancer       Date:  2014-12       Impact factor: 3.720

8.  More than Meets the Eye: Metastatic Uveal Melanoma.

Authors:  Cathy I Cheng; Susanna S Park; Paul Aronowitz
Journal:  J Gen Intern Med       Date:  2016-05-02       Impact factor: 5.128

Review 9.  Small Bowel Lesions Mimicking Crohn's Disease.

Authors:  David B Sachar
Journal:  Curr Gastroenterol Rep       Date:  2018-08-06

Review 10.  Optimal management of metastatic melanoma: current strategies and future directions.

Authors:  Marta Batus; Salman Waheed; Carl Ruby; Lindsay Petersen; Steven D Bines; Howard L Kaufman
Journal:  Am J Clin Dermatol       Date:  2013-06       Impact factor: 7.403

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.